Our Services

BioepiNet is at the forefront of epidemiology research and practice. Our epidemiology services are offered by a team of Ph.D. epidemiologists, MD physician-scientists, and Ph.D. biostatisticians and statisticians.

Specialty areas of interest include:

• Incidence and prevalence data
• Epidemiology of chronic and infectious diseases
• Investigation of risk factors for health outcomes
• Systematic literature reviews and meta-analyses
• Risk assessment and analysis
• Medical claims data (commercial claims, Medicare)
• Electronic health record (EHR) data
• Evaluation of interventions and programs
• Assessing medication efficacy and safety
• Comparative effectiveness research
• Appropriate epidemiologic methodologies
• Research design, conduct, analysis, interpretation and reporting of results
• Defining research question and objectives, matching the research question to strategy and design, and designing the research protocol
• Data collection, analysis, and preparation of reports and journal articles
• Systematic literature reviews to identify research gaps, synthesize information, and manuscript preparation
• Development of educational materials, workshops, training, webinars and more

BioepiNet uses a scientific rigor and integrity to create evidence from observational data sources as well as clinical research data. Our team has worked with population-based survey data, health registries, medical claim data (commercial claims, Medicare), electronic health record data, and clinical trial data. We are comfortable with both simple and sophisticated research approaches as required.

Role of clinical researchers and epidemiologists in advancing medical science

All through medical history, humanity has witnessed myriads of advancements that have reshaped how diseases are prevented and managed. These advancements range from public health measures that help reduce infectious diseases to the creation of new drugs and vaccines. Also, scientists have developed more potent diagnostic devices with the advent of tools like nanotechnology, data science, particle accelerators, robotics, artificial intelligence, and laser technology. Today, we are witnessing even more accelerated discoveries despite the pandemic and other socio-economic setbacks.

In 2020, gene editing made the headlines when two clinical researchers discovered the CRISPR/Cas9 genetic scissors, which could help rewrite the DNA. It also will immensely benefit people with genetic conditions like sickle cell disease. Another groundbreaking advancement within the same year was the Phase III studies that could benefit patients with conditions like atrial fibrillation and hypertrophic cardiomyopathies.

Further, we now have more targeted therapies and “drug” genetic mutations in cancer treatment. Also in the list of medical advancements that have improved disease outcomes are telemedicine and blood tests usage in the diagnosis of Alzheimer’s disease.

Advancing medical science: The role of clinical researchers and epidemiologists

At the heart of all medical advancements are epidemiology and clinical research. The role of researchers is to identify novel ways to prevent, diagnose, or manage disease conditions. These developments might be in the form of pharmacological interventions, surgical procedures, or novel ways of using old treatments. In carrying out these responsibilities, these experts design and run multiphasic trials that determine the safety and efficacy of new treatment models.

The trial phases, which take a considerable amount of time, ensure that there’s appropriate data and risk analysis on any novel treatment model. For instance, recent clinical trials have created novel therapeutic models for the diagnosis and management of prostate cancer. Through a clinical researcher’s lens, it is apparent that managing this condition has significantly improved from the traditional orchiectomy to newer and less invasive modalities like immunotherapy.

In the same vein, epidemiologist consultants study disease deterrent, distribution, and determinants. These responsibilities entail carrying out studies that help outline disease risk factors and possible etiologies. If these risk factors are modifiable, an astute epidemiologist consultant will further expatiate, with the help of research consulting companies, common lifestyle remedies that could help manage such conditions. For example, the recent identification of the etiology, risk of transmission, and development of a potent COVID 19 vaccine was majorly borne out of epidemiologic surveys.

Furthermore, the fruit of clinical research consultancy and epidemiology consulting units has gone even beyond providing present solutions to predicting future disease entities and outbreaks. This claim is not far-fetched because, as long as verifiable data on past and present disease conditions exist, these experts can make impeccable analyses and projections to identify possible pathogenic sources.

To sum it up, the role of clinical research and epidemiology in advancing medical science cannot be overemphasized. The reason is that input from these disciplines will never cease to be the bedrock and engine that drives novel medical discoveries and solutions.